Activation of TRPV4 receptors in the GI tract has a pro-inflammatory effect, and selective blockade of TRPV4 in an animal model of IBD alleviated colitis and the pain associated with intestinal inflammation. The gene discussed is TRPV4; the disease is inflammatory bowel disease.